Literature DB >> 17636281

Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study.

A M E Lintsen1, M J C Eijkemans, C C Hunault, C A M Bouwmans, L Hakkaart, J D F Habbema, D D M Braat.   

Abstract

BACKGROUND: The Dutch IVF guideline suggests triage of patients for IVF based on diagnostic category, duration of infertility and female age. There is no evidence for the effectiveness of these criteria. We evaluated the predictive value of patient characteristics that are used in the Dutch IVF guideline and developed a model that predicts the IVF ongoing pregnancy chance within 12 months.
METHODS: In a national prospective cohort study, pregnancy chances after IVF and ICSI treatment were assessed. Couples eligible for IVF or ICSI were followed during 12 months, using the databases of 11 IVF centres and 20 transport IVF clinics. Kaplan-Meier analysis was performed to estimate the cumulative probability of an ongoing pregnancy, and Cox regression was used for assessing the effects of predictors of pregnancy.
RESULTS: 4928 couples starting IVF/ICSI treatment were prospectively followed. On average, couples had 1.8 cycles in 12 months for both IVF and ICSI. The 1-year probability of ongoing pregnancy was 44.8% (95% CI 42.1-47.5%). ICSI for severe oligospermia had a significantly higher ongoing pregnancy rate than IVF indicated treatments, with a multivariate Hazard ratio (HR) of 1.22 (95% CI 1.07-1.39). The success rates were comparable for all diagnostic categories of IVF. The highest success rate is at age 30, with a slight decline towards younger women and women up to 35 and a sharp drop after 35. Primary subfertility with a HR of 0.90 (95% CI 0.83-0.99) and duration of subfertility with a HR of 0.97 (95% CI 0.95-0.99) per year significantly affected the pregnancy chance.
CONCLUSIONS: The most important predictors of the pregnancy chance after IVF and ICSI are women's age and ICSI. The diagnostic category is of no consequence. Duration of subfertility and pregnancy history are of limited prognostic value.

Entities:  

Mesh:

Year:  2007        PMID: 17636281     DOI: 10.1093/humrep/dem183

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  38 in total

1.  "Research on Infertility: Definition Makes a Difference" Revisited.

Authors:  Melanie H Jacobson; Helen B Chin; Ann C Mertens; Jessica B Spencer; Amy Fothergill; Penelope P Howards
Journal:  Am J Epidemiol       Date:  2018-02-01       Impact factor: 4.897

2.  Differences in cumulus cells gene expression between modified natural and stimulated in vitro fertilization cycles.

Authors:  Tanja Burnik Papler; Eda Vrtačnik Bokal; Klementina Fon Tacer; Peter Juvan; Irma Virant Klun; Rok Devjak
Journal:  J Assist Reprod Genet       Date:  2013-11-13       Impact factor: 3.412

3.  To what extent does Anti-Mullerian Hormone contribute to a better prediction of live birth after IVF?

Authors:  Catherine Rongieres; Carolina Colella; Philippe Lehert
Journal:  J Assist Reprod Genet       Date:  2014-11-05       Impact factor: 3.412

4.  Natural procreative technology for infertility and recurrent miscarriage: outcomes in a Canadian family practice.

Authors:  Elizabeth Tham; Karen Schliep; Joseph Stanford
Journal:  Can Fam Physician       Date:  2012-05       Impact factor: 3.275

5.  Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.

Authors:  Philippe Merviel; Michel Menard; Rosalie Cabry; Florence Scheffler; Emmanuelle Lourdel; Marie-Thérèse Le Martelot; Sylvie Roche; Jean-Jacques Chabaud; Henri Copin; Hortense Drapier; Moncef Benkhalifa; Damien Beauvillard
Journal:  Reprod Sci       Date:  2020-09-04       Impact factor: 3.060

6.  Predictors of treatment failure in young patients undergoing in vitro fertilization.

Authors:  Marni B Jacobs; Hillary Klonoff-Cohen; Sanjay Agarwal; Donna Kritz-Silverstein; Suzanne Lindsay; V Gabriel Garzo
Journal:  J Assist Reprod Genet       Date:  2016-05-06       Impact factor: 3.412

7.  Variability in the components of high-density lipoprotein particles measured in human ovarian follicular fluid: a cross-sectional analysis.

Authors:  Michael S Bloom; Keewan Kim; Victor Y Fujimoto; Richard W Browne
Journal:  Fertil Steril       Date:  2014-02-26       Impact factor: 7.329

Review 8.  Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis.

Authors:  Philippe Lehert; Joan C Schertz; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2010-09-16       Impact factor: 5.211

9.  Natural IVF cycles may be desirable for women with repeated failures by stimulated IVF cycles.

Authors:  Toshiki Matsuura; Yuji Takehara; Hirotsune Kaijima; Shokichi Teramoto; Osamu Kato
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

10.  A strict infertility diagnosis has poor agreement with the clinical diagnosis entered into the Society for Assisted Reproductive Technology registry.

Authors:  Thomas A Molinaro; Alka Shaunik; Kathleen Lin; Mary D Sammel; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2009-07-26       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.